Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

NCT00256282 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Vinorelbine
DRUG: Docetaxel
DRUG: Sargramostim

Sponsor

John P. Fruehauf

Collaborators

[object Object]